Linnane Pharma AB
Developing novel drugs for cancer and infections via proprietary platform.
Oversigt
- Ukendt
- Medarbejdere
- Ukendt
- Omsætning
- 2013
- Grundlagt
Nøglebeslutningstagere
Ines Ambite
Board Member
Catharina Svanborg
Chairman of the Board
Per Olof Gunnesson
Board Member
Göran Streiffert
Board Member
+6 flere kontakter i Funnelfeedr
Beskrivelse
Linnane Pharma operates as a parent holding company focused on developing groundbreaking scientific discoveries into novel therapeutic agents. Its primary mission is to alleviate suffering caused by cancer and severe bacterial infections, thereby reducing reliance on toxic chemotherapy and combating...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Holdingverksamhet i icke-finansiella koncerner
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556949434601
Beslutningstagere
10 kontakter i FunnelfeedrInes Ambite
Board Member
Catharina Svanborg
Chairman of the Board
Per Olof Gunnesson
Board Member
Göran Streiffert
Board Member
Jakob Testad
CEO
Andre kontakter
Shahram Ahmadi
PhD Candidate, Medical Microbiology
Murphy Wan
Research Project Participant at Cancer Infection
Samudra Sabari
Research Project Participant at Cancer Infection
Hien Tran
Researcher
+1 flere kontakter i Funnelfeedr
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Hamlet BioPharma AB
5–9 medarbejdereInnovative pharmaceutical company developing targeted cancer and infection treatments.
Ascelia Incentive AB
0 medarbejdereBiotech developing novel orphan oncology drugs for unmet medical needs.
Ascelia Pharma AB
Biotech developing novel orphan oncology drugs for unmet needs.
Oncopeptides AB
20–49 medarbejdereDeveloping targeted cancer therapies for difficult-to-treat diseases.
Inicure AB
0 medarbejdereDeveloping novel small molecules to combat resistant bacterial infections effectively.
Udforsk mere
Spørgsmål om Linnane Pharma AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo